High serum vascular endothelial growth factor C predicts better relapse-free survival in early clinically node-negative breast cancer.

Oncotarget · 2018 · PMC6021352 · PMID 29963266

Europe PMC DOI

hedged sentence

0.0640

closest p · 1.3× alpha

0.0640

boldest claim

The sentences

did not reach statistical significancep = 0.064so close (0.05 < p ≤ 0.1)

Likewise, Table 2 displays the RFS according to different percentiles of serum VEGF-C levels, again demonstrating that the RFS was better for patients with VEGF-C levels above the 75th percentile compared to patients with levels below the 75th percentile, although the results did not reach statistical significance (RFS 97.7%, p = 0.064).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.